• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌患者接受调强放疗时唾液流量分析及并发症发生率的剂量-体积建模

Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.

作者信息

Marzi Simona, Iaccarino Giuseppe, Pasciuti Katia, Soriani Antonella, Benassi Marcello, Arcangeli Giorgio, Giovinazzo Giuseppe, Benassi Michaela, Marucci Laura

机构信息

Laboratorio di Fisica Medica e Sistemi Esperti, Istituto Regina Elena, Rome, Italy.

出版信息

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1252-9. doi: 10.1016/j.ijrobp.2008.11.020.

DOI:10.1016/j.ijrobp.2008.11.020
PMID:19251097
Abstract

PURPOSE

To investigate dose-volume effects of salivary flow and the functional recovery over time, using salivary function data and different models of normal tissue complication probability (NTCP).

METHODS AND MATERIALS

A total of 59 patients with head-and-neck cancer treated with intensity-modulated radiotherapy (IMRT) were analyzed in the present study. The toxicity was evaluated using the Radiation Therapy Oncology Group (RTOG) scale and salivary flows, both unstimulated (USF) and stimulated (SSF). The assessments were done before radiotherapy (RT) and at 3, 6, 12, 18, and 24 months after RT. Grade 3 toxicity was the primary endpoint. Analyses of toxicity incidence at 3, 6, and 12 months after RT were performed by both the Lyman-Kutcher-Burman (LKB) and relative seriality (S) models.

RESULTS

A significant correlation was found between the incidence of Grade 3 toxicity and the incidence of patients with a reduction in SSF to <25% of the pre-RT value. Better correlations resulted between the RTOG toxicity score and the dosimetric parameters, compared with USF/SSF. The TD(50), assessed by the LKB model, was 21.4, 27.8, and 41.6 Gy at 3, 6, and 12 months after RT, respectively. The TD(50), assessed by the S model, was 20.0, 26.3, and 40.0 Gy at 3, 6, and 12 months after RT, respectively.

CONCLUSION

Recovery of salivary gland function vs. time after RT took place mostly within 1 year after RT. The RTOG Grade 3 was a reliable score to perform the NTCP modeling. The choice of NTCP model had no influence on the accuracy of predictions.

摘要

目的

利用唾液功能数据和不同的正常组织并发症概率(NTCP)模型,研究唾液流量的剂量 - 体积效应以及随时间的功能恢复情况。

方法和材料

本研究分析了59例接受调强放射治疗(IMRT)的头颈癌患者。使用放射治疗肿瘤学组(RTOG)量表以及静息唾液流量(USF)和刺激唾液流量(SSF)评估毒性。评估在放疗(RT)前以及RT后3、6、12、18和24个月进行。3级毒性是主要终点。采用莱曼 - 库彻 - 伯曼(LKB)模型和相对序列性(S)模型对RT后3、6和12个月的毒性发生率进行分析。

结果

发现3级毒性发生率与SSF降低至RT前值的<25%的患者发生率之间存在显著相关性。与USF/SSF相比,RTOG毒性评分与剂量学参数之间的相关性更好。通过LKB模型评估的TD(50)在RT后3、6和12个月分别为21.4、27.8和41.6 Gy。通过S模型评估的TD(50)在RT后3、6和12个月分别为20.0、26.3和40.0 Gy。

结论

放疗后唾液腺功能随时间的恢复大多发生在放疗后1年内。RTOG 3级是进行NTCP建模的可靠评分。NTCP模型的选择对预测准确性没有影响。

相似文献

1
Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.头颈部癌患者接受调强放疗时唾液流量分析及并发症发生率的剂量-体积建模
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1252-9. doi: 10.1016/j.ijrobp.2008.11.020.
2
A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.一种新的剂量限制方法,可减少调强放疗治疗头颈部癌症患者的口干症。
Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):269-76. doi: 10.1016/j.ijrobp.2009.07.1734. Epub 2010 Jan 25.
3
Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.头颈部癌放疗患者唾液功能的剂量-体积建模
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1055-69. doi: 10.1016/j.ijrobp.2004.12.076.
4
Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.放疗后腮腺功能的大型队列剂量-体积反应分析:调强放疗与传统放疗对比
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1101-9. doi: 10.1016/j.ijrobp.2008.02.059. Epub 2008 May 28.
5
Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.调强放射治疗可降低放射诱导的发病率并改善健康相关生活质量:一项使用标准化随访方案的非随机前瞻性研究结果
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):1-8. doi: 10.1016/j.ijrobp.2008.07.059. Epub 2008 Dec 26.
6
Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.头颈部癌逆向计划调强放射治疗(IMRT)后口腔健康相关生活质量和唾液流速的保留情况
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):663-73. doi: 10.1016/S0360-3016(03)01571-2.
7
Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.头颈部癌症患者接受或不接受对侧颌下腺保护的调强放疗后唾液腺剂量对唾液分泌和口干程度恢复的影响:一项纵向研究。
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1479-87. doi: 10.1016/j.ijrobp.2010.07.1990. Epub 2010 Oct 8.
8
Long-term parotid gland function after radiotherapy.放疗后的长期腮腺功能
Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):659-64. doi: 10.1016/j.ijrobp.2004.12.015.
9
A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.在一大群头颈部癌症患者中比较腮腺的剂量反应模型。
Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1259-65. doi: 10.1016/j.ijrobp.2009.07.1685. Epub 2009 Dec 16.
10
Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.描述调强放疗腮腺照射时流量减少的现象学模型:显著恢复效应的证据
Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):178-85. doi: 10.1016/j.ijrobp.2004.02.041.

引用本文的文献

1
The relevance of dental management prior to radiation therapy with severe oral mucositis in head and neck cancer patients.头颈部癌症患者在放疗前进行牙齿管理与严重口腔黏膜炎的相关性。
J Dent Sci. 2025 Jan;20(1):522-528. doi: 10.1016/j.jds.2024.04.030. Epub 2024 May 6.
2
Long-term outcomes of stimulated salivary flow and xerostomia after definitive intensity-modulated radiation therapy for patients with head and neck cancer†.头颈部癌症患者调强放疗后刺激性唾液分泌和口干的长期结果。
J Radiat Res. 2024 Jan 19;65(1):71-77. doi: 10.1093/jrr/rrad087.
3
National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer.
头颈部癌质子治疗基于模型选择的国家协议。
Int J Part Ther. 2021 Jun 25;8(1):354-365. doi: 10.14338/IJPT-20-00089.1. eCollection 2021 Summer.
4
Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.味觉刺激动态扩散加权 MR 成像评价调强放疗前后鼻咽癌患者唾液腺功能。
BMC Oral Health. 2019 Dec 21;19(1):288. doi: 10.1186/s12903-019-0951-x.
5
Three-dimensional dose prediction and validation with the radiobiological gamma index based on a relative seriality model for head-and-neck IMRT.基于头颈部调强放疗相对序列模型的三维剂量预测及放射性生物学伽马指数验证
J Radiat Res. 2017 Sep 1;58(5):701-709. doi: 10.1093/jrr/rrx017.
6
The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.使用基于单核苷酸多态性的模型预测放疗毒性:迈向预防的一步。
Semin Radiat Oncol. 2015 Oct;25(4):281-91. doi: 10.1016/j.semradonc.2015.05.006. Epub 2015 May 15.
7
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study.针刺样经皮电神经刺激与毛果芸香碱治疗放射性口干症的比较:RTOG 0537 三期研究结果
Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):220-7. doi: 10.1016/j.ijrobp.2015.01.050. Epub 2015 Apr 1.
8
Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas.螺旋断层放疗、正向调强放疗和两阶段适形计划对头颈部鳞癌根治性放疗的剂量学和放射生物学比较。
Br J Radiol. 2011 Dec;84(1008):1083-90. doi: 10.1259/bjr/53812025.
9
IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique.IsoBED:一种使用调强放疗(IMRT)联合同步整合推量(SIB)技术自动计算生物等效分割方案的工具。
J Exp Clin Cancer Res. 2011 May 9;30(1):52. doi: 10.1186/1756-9966-30-52.
10
Investigations on parotid gland recovery after IMRT in head and neck tumor patients.头颈部肿瘤患者调强放疗后腮腺功能恢复的研究。
Strahlenther Onkol. 2010 Dec;186(12):665-71. doi: 10.1007/s00066-010-2157-7. Epub 2010 Nov 30.